Quantcast
Aspirin May Reduce The Risk Of Blood Clots Reoccurring

Aspirin May Reduce The Risk Of Blood Clots Reoccurring

American Heart Association Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal...

Latest Warfarin Stories

2014-08-28 08:27:34

Company poised to enter final pivotal trial for novel oral anti-coagulant MENLO PARK, Calif., Aug. 28, 2014 /PRNewswire/ -- Armetheon, Inc. (www.armetheon.com), a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing. The Series A round was co-led by AshHill Biomedical Investments and Hercules Bioventures with participation from investors that included...

2014-08-27 23:12:45

A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C. (PRWEB) August 27, 2014 A recently published study by the Journal of Neurosurgery discusses the importance of time in correcting coagulopathy to prevent permanent injury or death. The study focuses on a variety of anticoagulants and examines medical conditions alleged to be caused by these drugs. According to the research, although...

2014-08-25 08:27:37

-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014 Hot Line Session RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that results from the Phase 3b exploratory X-VeRT study, investigating the oral Factor Xa inhibitor XARELTO(®) (rivaroxaban) in patients with non-valvular atrial...

2014-08-25 08:27:31

Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from nine company-sponsored Pradaxa® (dabigatran etexilate mesylate) studies will be presented at the European Society of Cardiology (ESC) Congress 2014, August 30 to September 3 in Barcelona, Spain. The abstracts will feature data about the use...

2014-08-21 23:03:25

The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered uncontrollable internal bleeding or other serious injuries allegedly due to their use of the blood thinner. New York, New York (PRWEB) August 21, 2014 Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) filings that allege the blood thinner caused patients to suffer uncontrollable internal bleeding and other serious injuries continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According to court...

2014-08-13 23:11:30

Thousands of Pradaxa Lawsuits Currently Pending in U.S. Courts Accuse Boehringer Ingelheim of Failing to Provide Adequate Warnings Regarding Medication’s Alleged Bleeding Side Effects New York NY (PRWEB) August 13, 2014 Pradaxa Lawsuit News: As Pradaxa lawsuits continue to move forward in U.S. courts, several new reports published in the British Medical Journal are raising new questions about the data used to garner regulatory approval of the blood thinner. Among other things, the...

2014-08-13 23:02:06

The Firm is evaluating Xarelto lawsuits on behalf of individuals who allegedly suffered intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death due to their use of the blood thinner. New York, NY (PRWEB) August 13, 2014 Xarelto lawsuits (http://www.injurybeacon.com/xarelto/lawsuit/) filed on behalf of individuals who were allegedly harmed by the blood thinner continue to mount in U.S....

2014-08-09 23:03:28

Court Documents Indicate a Number of Xarelto Bleeding Lawsuits Have Been Filed In U.S. Courts on Behalf of Individuals Who Allegedly Suffered Life-Threatening Internal Hemorrhage Due to Their Use of the Blood Thinner Columbus, OH (PRWEB) August 09, 2014 Wright & Schulte LLC has launched a new Xarelto lawsuit page in response to the growing litigation involving the blood thinner. According to a Reuters report published June 14, 2014, Bayer AG and Janssen Pharmaceuticals are named as...

2014-07-30 23:01:48

The Firm is investigating Xarelto lawsuits on behalf of individuals who allegedly suffered uncontrollable bleeding, strokes, deep vein thrombosis, or pulmonary embolism due to the blood thinner. New York, New York (PRWEB) July 30, 2014 The family of a Vermont man who died from uncontrollable brain bleeding has filed a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/ ) alleging his death was caused by the blood thinner, Bernstein Liebhard LLP reports. According to the complaint, which...

2014-07-23 16:26:55

British Medical Journal publishes biased article regarding PRADAXA RIDGEFIELD, Conn., July 23, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that this publication may alarm patients and prompt them to stop taking PRADAXA, thereby increasing their risk of stroke. To be clear, many of the allegations made...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related